drugset / Trial / NCT00712413

Safety, Efficacy of Pylera BID Dosing in Eradication of H. Pylori

NCT00712413

Phase 3 Withdrawn Forest Laboratories
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effect of Pylera when given twice a day. Pylera approved treatment schedule is 3 pills taken 4 times daily, in addition to omeprazole given twice daily. In this trial, subjects with confirmed Helicobacter Pylori infection will receive Pylera treatment and omeprazole twice daily.

Timeline

Start
2008-08
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Metronidazole Small molecule 125 mg
Subject Tetracycline Unknown 125 mg
Subject bismuth subcitrate Unknown 40 mg
Background Omeprazole Other / unclassified 20 mg